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 28 
ABSTRACT 29 
Introduction: Nicotinamide nucleotide transhydrogenase, NNT, is a ubiquitous protein of the 30 
inner mitochondrial membrane with a key role in mitochondrial redox balance. NNT produces 31 
high concentrations of NADPH for detoxification of reactive oxygen species by glutathione 32 
and thioredoxin pathways.  In humans, NNT dysfunction leads to an adrenal specific 33 
disorder, glucocorticoid deficiency. Certain sub-strains of C57BL/6 mice contain a 34 
spontaneously occurring inactivating Nnt mutation and display glucocorticoid deficiency 35 
along with glucose intolerance and reduced insulin secretion. To understand the underlying 36 
mechanism(s) behind the glucocorticoid deficiency we performed comprehensive RNA-seq 37 
on adrenals from wild-type (C57BL/6N), mutant (C57BL/6J) and BAC transgenic mice 38 
overexpressing Nnt (C57BL/6JBAC). Results: Our data suggests that Nnt deletion (or 39 
overexpression) reduces adrenal steroidogenic output by decreasing expression of crucial, 40 
mitochondrial antioxidant (Prdx3 and Txnrd2) and steroidogenic (Cyp11a1) enzymes. 41 
Pathway analysis also revealed upregulation of heat shock protein machinery and 42 
haemoglobins possibly in response to the oxidative stress initiated by NNT ablation. 43 
Conclusion: Using transcriptomic profiling in adrenals from three mouse models we showed 44 
that disturbances in adrenal redox homeostasis are mediated not only by under expression 45 
of NNT but also by its overexpression. Further we demonstrated that both under- or 46 
overexpression of NNT reduced corticosterone output implying a central role for it in the 47 
control of steroidogenesis. This is likely due to a reduction in the expression of a key 48 
steroidogenic enzyme, Cyp11a1, which mirrored the reduction in corticosterone output. 49 
 50 
BACKGROUND  51 
Adrenal insufficiency is a rare, potentially fatal, endocrine disorder resulting from a failure of 52 
the adrenal cortex to respond to hormonal stimuli. In Familial (or isolated) Glucocorticoid 53 
Deficiency adrenal hormone output is preserved apart from a specific deficit of 54 
glucocorticoids. Normally, under the control of hypothalamic Corticotropin Releasing 55 
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Hormone (CRH) and arginine vasopressin (AVP), the pituitary releases Adrenocorticotropic 56 
hormone (ACTH) which acts on the adrenal via the ACTH receptor (otherwise known as 57 
MC2R) to produce glucocorticoids, mainly cortisol. This in turn acts on the hypothalamus 58 
and pituitary to suppress further production of ACTH in a negative feedback loop [Figure 1A] 59 
[Keller-Wood & Dalman 1984]. The human adult adrenal is characterised by three distinctive 60 
cortical zones surrounding the medulla; the zona glomerulosa (ZG) where mineralocorticoids 61 
are produced, the zona fasciculata (ZF) which synthesises glucocorticoids (mostly cortisol; in 62 
mice, the major glucocorticoid is corticosterone) and the zona reticularis (ZR) where 63 
androgen synthesis occurs [Vinson 2003]. The first step of steroidogenesis occurs once 64 
cholesterol is transported from the outer to the inner mitochondrial membrane by the 65 
steroidogenic acute regulatory protein (STAR) and is converted to pregnenolone by the 66 
cholesterol side chain cleavage enzyme (CYP11A1). To make cortisol, pregnenolone then 67 
undergoes a series of intermediate reactions catalysed by microsomal enzymes (CYP17A1, 68 
HSD3B2 and CYP21A2) before the final step of cortisol production, catalysed by 11beta-69 
hydroxylase (CYP11B1) or aldosterone production, catalysed by CYP11B2, both occurring in 70 
mitochondria, [Figure 1B] [Miller & Auchus 2011]. The activities of steroidogenic cytochrome 71 
P450 (CYP) enzymes are reliant upon electron-donating redox partners; for mitochondrial (or 72 
Type 1) enzymes, electrons are transferred from the reduced form of nicotinamide adenine 73 
dinucleotide phosphate (NADPH) by ferredoxin reductase (FDXR) and ferredoxin (FDX1) 74 
whereas the microsomal enzymes (Type 2) use P450 oxidoreductase (POR) as their redox 75 
partner. Hence the first and last steps of cortisol production occur in the mitochondria and 76 
require a constant supply of reductant NADPH. This NADPH is regenerated from NADP by a 77 
few pathways including the thioredoxin and glutathione pathways, which are ultimately 78 
enabled by NNT [Figure 2]. 79 
Perturbations in this pathway cause a number of steroidogenic defects affecting adrenal and 80 
gonadal steroidogenesis. STAR mutations give rise to lipoid congenital adrenal hyperplasia 81 
(OMIM 201710) a severe syndrome of adrenal and gonadal insufficiency resulting in XY sex 82 
reversal, CYP11A1 defects give a similar clinical picture but without the lipid build up in 83 
Page 3 of 41
steroidogenic tissues seen with STAR mutations. HSD3B2, CYP17A1, CYP21A2, CYP11B1, 84 
and POR mutations give rise to four variants of congenital adrenal hyperplasia (OMIM 85 
201810, 202110, 201910, 202010, and 201750 respectively) and CYP11B2 mutations give 86 
rise to hypoaldosteronism (OMIM 203400) [Figure 1B] [Miller & Auchus 2011]. No mutations 87 
have yet been described in humans in FDXR/FDX1 – perhaps due to embryonic lethality. 88 
Partial loss-of-function changes in STAR and CYP11A1 can present with a less severe 89 
phenotype akin to our disease of interest, Familial or isolated Glucocorticoid Deficiency 90 
(FGD) [Baker et al., 2006; Metherell et al., 2009; Rubtsov et al., 2009; Sahakitrungruang et 91 
al., 2010; Parajes et al., 2011; Sahakitrungruang et al., 2011]. In FGD, the two most 92 
common gene defects are mutations in the melanocortin 2 receptor and its accessory protein 93 
(MC2R and MRAP), but recently we have described defects in NADPH supply to and/or 94 
antioxidant defence in mitochondria, with defects in two genes, NNT and thioredoxin 95 
reductase 2 (TXNRD2), giving disorders of adrenal insufficiency primarily compromising 96 
glucocorticoid production [Meimaridou et al., 2012; Meimaridou et al., 2013; Prasad et al., 97 
201]. MC2R and MRAP are adrenal zone and ACTH pathway specific so it is unsurprising 98 
that they give rise to isolated glucocorticoid deficiency whereas NNT and TXNRD2 are 99 
ubiquitously expressed. 100 
NNT is the major mitochondrial enzymatic source of NADPH contributing 45% of the total 101 
NADPH supply [Nickel et al., 2015]. It exists as a dimer and spans the inner mitochondrial 102 
membrane modulating H+ movement and supplying the high concentrations of NADPH 103 
required for the detoxification of ROS by glutathione and thioredoxin pathways [Figure 2]. 104 
Even though the gene is ubiquitously expressed, the organ specific physiological roles of 105 
NNT are only gradually being revealed by the study of a C57BL/6J mouse substrain that has 106 
a spontaneous mutation in Nnt (an in frame 5-exon deletion) resulting in the truncation of the 107 
message and absence of the protein [Nickel et al., 2015]. The first consequence of this 108 
murine Nnt deletion, described by Toye et al in 2005, was glucose intolerance and reduced 109 
insulin secretion. Subsequent to the finding of human mutations causing FGD we showed 110 
that 3-month-old mice had 50% lower basal and stimulated levels of corticosterone than their 111 
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wild-type counterparts. Histological examination of their adrenals revealed a slightly 112 
disorganized zona fasciculata with higher levels of apoptosis than the wild-type C57BL/6N 113 
strain [Meimaridou et al., 2012].  More recently it was reported that liver mitochondria from 114 
C57BL/6J mice have major redox impairments resulting in an inability to maintain NADP and 115 
glutathione in their reduced states [Ronchi et al., 2013].  116 
Previously, we have shown that H295R cells where Nnt has been stably knocked down 117 
undergo oxidative stress as demonstrated by low glutathione levels, and increased 118 
mitochondrial superoxide production [Meimaridou et al., 2012]. Similar defects in energy 119 
metabolism due to Nnt ablation have also been demonstrated in other mouse tissues (heart, 120 
liver, pancreas) emphasising the importance of NNT for cellular bioenergetics [Sauer et al., 121 
2004; Ronchi et al., 2013; Nickel et al., 2015]. However, the mechanism by which loss of Nnt 122 
causes the adrenal specific pathology we observe is unclear.  123 
 124 
Here we aim to investigate the effect of NNT loss and overexpression in the adrenal cortex 125 
by performing RNA-seq on adrenals from mice which are wild-type (C57BL/6N, Nnt+/+), null 126 
(C57BL/6J, Nnt-/-), or 2-fold overexpressors (BAC transgenic, NntBAC) of Nnt [Freeman et al., 127 
2006].   128 
 129 
MATERIALS AND METHODS  130 
Mouse strains 131 
All mice were bred, housed and culled at MRC Harwell and therefore the husbandry was 132 
identical for all 3 substrains. The mouse strains used were C57BL/6NHsd originally from 133 
Harlan (Harlan Laboratories UK) which is wild-type for Nnt (Nnt+/+), C57BL/6J originally from 134 
Charles River (Charles River UK Ltd) which has an in-frame deletion of 5 Nnt exons (Nnt-/-) 135 
and C57BL/6J mice carrying a BAC transgene to restore murine Nnt (NntBAC; [Freeman et 136 
al., 2006]) which we show are 2-fold overexpressors.  For RNA-seq 18-month-old male mice 137 
of the three different substrains were utilised, 5 mice per group. Mice were culled with an 138 
overdose of Euthatal (to allow for the collection of blood) and tissues were then removed 139 
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quickly and either fixed or flash frozen in liquid nitrogen. All mice were culled between 10 140 
and 11.30 am and adrenals removed. The animal protocols used in this study were 141 
approved by United Kingdom Home Office.  142 
 143 
Genotyping 144 
Genomic DNA was extracted from the mouse tail tissue using a Qiagen DNeasy tissue kit. 145 
Mice were genotyped for Nnt status using previously published primers [Huang et al., 2006].  146 
 147 
Mouse histology 148 
Mouse adrenals from Nnt+/+, Nnt-/- and NntBAC were fixed in 4% paraformaldehyde (Sigma) 149 
and embedded in paraffin. Sections were obtained using a microtome (Microm HM 325, 150 
Thermo Fisher) at 6-µm thickness, Hematoxylin & Eosin (H&E) staining was performed 151 
using standard procedures [Guasti et al., 2011]. 152 
To assess changes in lipid content between the three mice strain, we performed oil red O 153 
staining as described previously 154 
(www.ihcworld.com/_protocols/special_stains/oil_red_o.htm). Briefly sections of fresh frozen 155 
adrenal tissues were obtained at 5µm thickness and fixed in ice cold 10% formalin for 5 156 
mins. Sections were air dried and placed in absolute propylene glycol for 5 mins to avoid 157 
carrying water into Oil Red O. Sections were then stained with pre-warmed Oil Red O 158 
solution for 8-10min at 60oC and then washed twice with distilled water. Images were 159 
acquired using a Leica DMR microscope (Leica), and digital images were captured using a 160 
Leica DC200 camera (Leica) and DCViewer software (Leica).  161 
 162 
Steroid profile 163 
Serum steroids were quantified using liquid chromatography-tandem mass spectrometry 164 
(LC-MS/MS) as previously described [O’Reilly et al., 2014]. Steroids were extracted from 165 
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200µl of serum (after addition of internal standard) using 1ml tert-butyl methyl ether (MTBE). 166 
After freezing at -20 0C for 1 hour, the MTBE layer was transferred into a 96-well plate and 167 
evaporated under nitrogen at 55˚C. Samples were reconstituted in 125 µl of a 50:50 solution 168 
of Methanol (Sigma) and H2O (Sigma). Steroids were analysed on a Waters Xevo with 169 
Acquity uPLC, steroids were eluted from a HSS T3 1.8µm, 1.2x50mm column with a 170 
methanol/water 0.1% formic acid gradient system. Two mass transitions were used to 171 
identify and quantify each steroid (corticosterone: 347.2 > 121.2 and 347.2 > 97; 172 
deoxycorticosterone: 331 > 97 and 331 > 109. 173 
 174 
Generation of stable NNT knockdown (KD) and scrambled (SCR) H295R cell lines  175 
Lentiviral plasmids (RHS4430-98851990; RHS4430-98913600; RHS4430-98524425; 176 
RHS4430-101033169 RHS4430-101025114) were obtained from OpenBiosystems in a 177 
p.GIPZ backbone and contained shRNA specific for human NNT (NM 012343) under the 178 
control of the CMV promoter, plus the puromycin resistance and green fluorescence protein 179 
(GFP) genes. HEK293T cells (packaging cells) were transiently transfected with the shRNA 180 
plasmids, two days after transfection virus containing media was collected, filtered using a 181 
0.22µm filter and used to transduce H295R cells. Four days after infection GFP-positive cells 182 
were selected in 4µg/ml puromycin. Transduction efficiency was determined by fluorescence 183 
microscopy. A scrambled (control) cell line was generated in a similar fashion using a non-184 
specific shRNA. 185 
 186 
NADP/NADPH assay 187 
To measure total and reduced nicotinamide adenine dinucleotide phosphates (NADP+ and 188 
NADPH respectively) stably transfected H295R cells were plated onto white-walled and 189 
white bottomed 96-well culture dishes (Corning Costar). After 24hrs, NADP+ and NADPH 190 
were measured using NADP/NADPH-Glo assay (Promega), a luminescence based system 191 
and according to the manufacturer’s protocol. Luminescence was recorded after 15min using 192 
Omega Luminometer (BMGLabTech) and with integration time of 0.5 sec.  193 
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 194 
Oxygen Consumption rate- XF Extracellular Flux Analyser 195 
Scrambled (SCR) and stable knock-down H295R cells (NNT-KD) were cultured on Seahorse 196 
XF-96 microplates and allowed to grow overnight. On the day of metabolic flux analysis, 197 
cells were changed to unbuffered DMEM (DMEM base medium supplemented with 10 mM 198 
glucose, 1 mM sodium pyruvate, 2 mM L-Glutamine, pH 7.4) and incubated at 37°C in a 199 
non-CO2 incubator for 1 h. All medium and injection reagents were adjusted to pH 7.4 on the 200 
day of assay. Baseline measurements of oxygen consumption rate (OCAR, measured by 201 
oxygen concentration change) and extracellular acidification rate (ECAR, measured by pH 202 
change) were taken before sequential injection of treatments / inhibitors: oligomycin (ATP 203 
synthase inhibitor, 4 µM), FCCP (mitochondrial respiration uncoupler, 1 µM), and rotenone 204 
(Complex I inhibitor, 1 µM).  205 
 206 
RNA-seq 207 
RNA from mouse adrenal tissues (Nnt+/+, Nnt-/-, NntBAC) was extracted using the RNeasy Mini 208 
kit (Qiagen). Once RNA quality and concentration were tested samples, were processed by 209 
Oxford Gene Technology (www.ogt.co.uk). Enrichment and library preparation were 210 
performed using Illumina TruSeq RNA Sample Prep Kit v2; Total RNA was captured with 211 
oligo-dT coated magnetic beads. The mRNA was fragmented and then first strand cDNA 212 
synthesis was initiated from random primers, followed by second strand synthesis. After end-213 
repair, phosphorylation and A-tailing, adapter ligation and PCR amplification was performed 214 
to prepare the library for sequencing. Paired-end sequencing was performed over 100 cycles 215 
on the Illumina HiSeq2000 platform using TruSeq v3 chemistry. Fastq files were generated 216 
from the sequencing platform via the manufacturer's proprietary software. For mapping and 217 
alignment reads were processed through Tuxedo suite [Trapnell et al., 2013]. Reads were 218 
mapped to their location on the appropriate Illumina iGenomes build using Bowtie and splice 219 
junctions were identified using Tophat. Cufflinks was used to perform transcript assembly, 220 
abundance estimation and differential expression and regulation for the samples. RNA-Seq 221 
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alignment metrics were generated using Picard.  222 
Lipid Peroxidation Assay. 223 
Lipid peroxidation in mouse adrenal lysates was assessed by using a lipid peroxidation 224 
assay kit (AbCam, UK) based on the detection of malondialdehyde (MDA) in the samples. 225 
Adrenal tissues from Nnt+/+, Nnt-/- and NntBAC mice were excised and homogenised in MDA 226 
lysis buffer provided in the kit. Lysates were then centrifuged at 13,000 x g for 10mins and 227 
the supernatant collected for lipid peroxidation measurements. Samples were incubated with 228 
thiobarbituric Acid (TBA) which interacts with MDA present in the samples to generate MDA-229 
TBA adducts. These adducts were quantified colorimetrically at 532 nm. 230 
 231 
Immunoblotting analysis 232 
Immunoblotting was used to assess protein expression. Cells were lysed in RIPA buffer 233 
containing protease and phosphatase inhibitors (SIGMA) and then left on ice for 30mins. 234 
Samples were centrifuged for 15mins at 13,000 rpm. Supernatant was collected and an 235 
equal volume of Laemmli buffer was added.  Samples were heated at 95-100oC for 5mins 236 
and then loaded on 4-12% SDS gels. Protein separation was performed by using the 237 
Invitrogen electrophoresis system. Proteins were then transferred to nitrocellulose 238 
membrane (Sigma Aldrich) using semi-dry transfer blot (Biorad) at 15V for 1hr. Membranes 239 
were probed with one of; mouse anti-Nnt (1:1000; SIGMA, HPA004829), mouse anti-actin 240 
(1:5000; SIGMA, A5441), rabbit anti-TXNRD2 (1:1000;SIGMA, SAB2702064), rabbit anti-241 
PRDX3 (1:500; ProteinTech, 55087-1-AP), rabbit anti-GPX1 (1:500; Abcam ab108429), 242 
mouse anti-STAR (1:1000;Abcam, ab58013), rabbit anti-CYP11A1 (1:1000;Cell Signalling, 243 
14217 ), rabbit anti-HSD3B2 (1:500; Aviva Biosystems, OAGA02009), rabbit anti-CYP21A2 244 
(1:500; SIGMA HPA053371). Visualisation of the proteins was performed by using Alexa-245 
fluor 680 and 800 secondary antibodies (1:5000; Invitrogen) and the Li-CoR Odyssey 246 
system.  247 
 248 
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 249 
Statistics 250 
Statistical analyses were performed using a combination of one-way Anova using Tukey 251 
HSD (honest significant difference) test and a two-tailed student’s t-tests assuming unequal 252 
variance in 5 mice per group. All values were expressed as a mean ± standard error of the 253 
mean and p values <0.05 were considered significant. 254 
 255 
RESULTS 256 
Mouse phenotyping 257 
We have previously reported that 3-month-old mice carrying a spontaneous Nnt 5-exon 258 
deletion (C57BL/6J, Nnt-/-) have significantly lower levels of corticosterone (50%) than their 259 
wild type counterparts (C57BL/6N, Nnt+/+) [Meimaridou et al., 2012]. To identify the 260 
mechanism by which loss of NNT affects steroidogenesis we employed the same mouse 261 
models but also included an additional mouse line where the Nnt loss had been rescued in 262 
C57BL/6J mice by transgenic expression of the entire murine Nnt gene contained within a 263 
bacterial artificial chromosome (BAC transgenic, NntBAC) [Freeman et al., 2006]  264 
 265 
Glucocorticoid levels in the three mouse strains 266 
The adrenal steroid output of the three mouse strains was measured at 18 months in murine 267 
serum samples employing liquid chromatography-tandem mass spectrometry (LC-MS/MS). 268 
Changes in steroid production were observed predominantly for corticosterone, with 269 
reduction to 14% of wild-type levels in Nnt-/- mice [Figure 3A]. Corticosterone levels in the 270 
NntBAC mice restored serum corticosterone in part, but only to 40% of wild-type (Nnt+/+) 271 
levels, suggesting that overexpression of Nnt also perturbs steroidogenesis. 11-272 
deoxycorticosterone levels were not significantly different amongst the mice and therefore 273 
the ratio of 11-deoxycorticosterone/corticosterone was significantly higher in Nnt-/- and 274 
NntBAC mice indicating lower enzyme activity of Cyp11b1 [Figure 3B]. We also noted that, 275 
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over time, the deficit in glucocorticoid output worsened for the Nnt-/- mice, between 3 and 18 276 
months corticosterone levels in Nnt+/+ were unaltered whereas there is a 60% decrease for 277 
Nnt-/- mice, suggesting progressive loss of function [Figure 3C]. 278 
 279 
No changes to adrenal histology 280 
In humans with FGD there is a specific loss of glucocorticoid output from the zona 281 
fasciculata and relative preservation of steroid output from the other zones suggesting loss 282 
of this specific zone. Consistent with these findings, Mc2r-/- mice have smaller adrenals with 283 
preservation of zona glomerulosa and medulla but atrophied zona fasciculata [Chida et al., 284 
2007]. Interestingly all Mc2r-/- mice on a pure C57BL/6J background die within two days of 285 
birth whereas those on a mixed B6/Balbc have much higher survival rates, with half making 286 
it to adulthood perhaps due to the restoration of Nnt levels [Chida et al., 2009], making Nnt a 287 
genetic modifier of their adrenal phenotype akin to the situation in another mouse model 288 
where NNT has a protective role in superoxide dismutase deficient mice [Huang et al., 289 
2006]. To determine whether loss of ZF occurs in Nnt-/- mice we performed H&E staining in 290 
adrenal sections from the three mouse substrains. This showed no morphological 291 
differences among the strains in adrenal zonation [Figure 3D]. This was supported by the 292 
finding that genes differentially expressed between zones were not altered (see below). This 293 
suggested no major remodelling of the adrenals due to NNT loss and gave us confidence 294 
that the RNA-seq variations were not due to changes in zonation. Furthermore, on Oil Red O 295 
staining, we observed no differences in lipid levels between the mouse strains suggesting 296 
there is neither a dearth of cholesterol supply for steroidogenesis nor a surplus due to a 297 
cholesterol transport defect as seen with Star mutations [Sasaki et al., 2008] [Figure 3E].  298 
 299 
Nnt deletion causes oxidative stress in mouse adrenals. 300 
We measured lipid peroxidation (LPO) by a malondialdehyde (MDA) assay as a measure of 301 
oxidative stress in these mice (5 mice per group). There was a significant increase in LPO in 302 
the adrenals of Nnt-/- mice which returned towards wild-type levels in NntBAC mice indicating 303 
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lipid damage by free radicals in adrenals upon Nnt deletion [Figure 4A]. We saw the same 304 
trend in H2O2 levels (increased in Nnt
-/- and reduced again in NntBAC) [Data not shown].  305 
Impaired redox homeostasis caused by lack of NNT was further supported by in vitro studies 306 
in human adrenocortical H295R cells. The total cellular NADP/NADPH ratio was significantly 307 
higher in H295R with lentiviral knockdown of NNT (NNT-KD) compared to scrambled control 308 
cells (SCR), suggesting that NNT is required to maintain the redox state of the intracellular 309 
NADPH and NADP+ pools [Figure 4B].  310 
The perturbation in NADP/NADPH balance affected mitochondrial respiration resulting in 311 
significantly lower oxygen consumption rates (OCAR) in cells where NNT is knocked down 312 
[Figure 4C].  313 
 314 
Transcriptome profiling by RNA-seq in adrenals from the C57BL/6 mouse substrains 315 
To investigate the cause of the reduced steroid production upon Nnt deletion, RNA was 316 
extracted from Nnt+/+, Nnt-/-, and NntBAC mouse adrenals and the transcriptome profiled by 317 
RNA-seq. Using an Illumina HiSeq 2000 sequencer we obtained an average of 30 million 318 
reads per sample, with ~98% of these reads mapped to the mouse reference genome. In 319 
total, 27,622 genes were analysed in Nnt+/+, Nnt-/- and NntBAC adrenals [Figure 5A & 320 
Supplementary Table 1]. The most highly expressed categories of genes were 321 
mitochondrially encoded electron transport chain genes (mt-Co1, mt-Co2, mt-Atp6, mt-Co3, 322 
mt-Cytb, mt-Nd4, mt-Nd2, mt-Nd1, mt-Atp8, mt-Nd6, mt-Nd5, mt-Nd4l, mt-Nd3, mt-Rnr1), 323 
followed by steroid pathway genes Star, Cyp21a1 and Hsd3b1, which are high up in the 324 
steroidogenic cascade [Supplementary Table 1] perhaps reflecting the high mitochondrial 325 
content of and high demand for steroidogenesis in the adrenal.  326 
Initial data analysis was performed between paired samples comparing Nnt+/+ and Nnt-/-, 327 
Nnt+/+ and NntBAC and Nnt-/- and NntBAC adrenals. To identify differentially expressed genes 328 
from each group we used the following criteria; (1) gene expression level greater than or 329 
equal to 1 read per kilobase of exon per million fragments mapped (RPKM) in all samples; 330 
(2) change in expression level greater than or equal to 1.5-fold; and (3) significance p value 331 
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< 0.05. This revealed differential expression (fold change ≥1.5; p<0.05) of 400 genes in total 332 
in the pairwise comparisons [Figures 5B, 5C and Supplementary Table 2]. Only 1 gene 333 
varied between all three pairwise analyses and that was Nnt itself (see below and Figure 334 
5C). We hypothesized that genes that were up- or down-regulated in Nnt-/- and their levels 335 
restored in NntBAC would be genes that were modulated by NNT. 336 
 337 
NNT levels in the three mouse strains 338 
Nnt expression levels in the three mouse strains were determined and while we observed 339 
very low mRNA levels in Nnt-/- mice (3.7-fold downregulation p = 0.012), there was a 2.7-fold 340 
(p = 1.8 x 10-5) increase in Nnt expression in NntBAC mice over that for Nnt+/+ [Figure 6A]. To 341 
investigate whether mRNA levels corresponded to protein expression we performed a 342 
western blot on adrenal lysates from the same mice. NNT was undetectable in the Nnt-/- 343 
mice whereas a two-fold increase in NNT was observed in the adrenals of NntBAC mice, in 344 
keeping with the RNA-seq data [Figure 6B]. These results suggest that the NntBAC 345 
represents a modest Nnt overexpressor. 346 
 347 
No differential expression of other genes with polymorphisms identified between sub-348 
strains 349 
Recently, comparative genomics between C57BL/6J and C57BL/6N strains has identified 350 
many SNPs and structural variants that may contribute to the phenotypic differences 351 
between the two strains [Simon et al., 2013]. To check whether these SNPs altered 352 
expression of these genes in the adrenal we specifically looked at their mRNA expression 353 
levels. Except for Cilp, which was up in NntBAC (1.6 fold over Nnt+/+ [p 0.013]) but unaltered 354 
between Nnt+/+ and Nnt-/, we found no alterations in expression levels of the genes with 355 
interstrain variations, suggesting that the effects we describe are largely due to differential 356 
Nnt levels.  357 
 358 
 359 
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No differential expression of zone specific genes between sub-strains 360 
Many genes show differential expression between the zones of the adrenal, classically for 361 
example tyrosine hydroxylase (Th), aldosterone synthase (Cyp11b2), 3-beta-hydroxysteroid 362 
dehydrogenase (Hsd3b2), cytochrome b5 (Cyb5) and aldo-keto reductase family 1 member 363 
C3 (Akr1c3). More recently transcriptomic analyses have identified hundreds of other genes 364 
with differential expression between ZF and ZG [Nishimoto et al., 2012; Rege et al., 2014]. 365 
None of these genes showed differential expression in our study suggesting no major 366 
remodelling of adrenals glands in Nnt-/- or NntBAC mice.  367 
 368 
Nnt deletion does not alter the levels of ACTH receptor pathway genes or other genes 369 
associated with adrenal insufficiency  370 
Mc2r expression was unaltered between Nnt+/+ vs Nnt-/- but up in NntBAC vs Nnt-/- (1.6-fold 371 
p=0.023) whereas Mrap levels were the same across the 3 groups (data not shown).  No 372 
significant expression level changes were observed at RNA level for other genes causing 373 
adrenal insufficiencies in humans (Aaas, Abcd1, Aire, Cdkn1c, Cyp11a1, Cyp11b1, 374 
Cyp17a1, Cyp21a1, Mcm4, Nr5a1, Por and Txnrd2).   375 
 376 
Nnt deletion alters antioxidant gene levels 377 
Nnt provides a constant supply of NADPH required for ROS detoxification by the thioredoxin 378 
and glutathione systems. Malic enzyme 3 (Me3) and isocitrate dehydrogenase 2 (Idh2) are 379 
alternate NADPH suppliers although NNT is the major contributor [14]. To investigate 380 
whether Nnt deletion leads to perturbation of other antioxidant enzymes perhaps to 381 
compensate for its loss, we looked at the mRNA and protein levels of antioxidant enzymes in 382 
these pathways. There was a modest reduction in gene expression levels of the antioxidants 383 
Prdx3 and Txnrd2 which did not reach statistical significance, however at the protein level 384 
they were significantly reduced in Nnt-/- mice vs Nnt+/+ and the levels remained significantly 385 
low in NntBAC when compared to Nnt+/+ [Figure 6C, 6D]. This is likely because NntBAC 386 
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overexpress NNT which may also cause redox imbalance, implying fine tuning of NNT is 387 
required for redox homeostasis.  We observed no compensatory increase in the alternative 388 
NADPH suppliers Me3 or Idh2. 389 
 390 
Nnt deletion alters mitochondrial cytochrome P450scc levels 391 
STAR is a protein involved in the transport of cholesterol from the outer to the inner 392 
mitochondrial membrane and specific partial loss-of-function mutations in STAR account for 393 
10% of FGD cases [Meimaridou et al., 2013].  Similarly, “mild” mutations in the cholesterol 394 
side chain cleavage enzyme (CYP11A1, the first enzyme in the steroid pathway), can give 395 
rise to FGD [Rubtsov et al., 2009; Parajes at el., 2011; Sahakitrungruang et al., 2011]. 396 
Mutations in 11β-hydroxylase (CYP11B1, the last enzyme in the glucocorticoid pathway) 397 
cause congenital adrenal hyperplasia. Previous work revealed that oxidative stress, resulting 398 
from the application of exogenous ROS, lead to inhibition of STAR protein expression and 399 
steroidogenesis in MA-10 Leydig cells, with no effect on CYP11A1 [Diemer et al., 2003]. We 400 
hypothesized that a similar phenomenon might occur with endogenous mitochondrial 401 
oxidative stress resulting from NNT deficit affecting Star and/or the mitochondrial CYP450 402 
enzymes, Cyp11a1 and Cyp11b1/b2. RNA-seq and western blot analysis showed no 403 
significant changes in the expression of Star at mRNA or protein level, indicating that a 404 
defect in cholesterol transport due to oxidative insult is an unlikely mechanism [Figure 7A, 405 
7C]. However, a suggestive 25% decrease in Cyp11a1, Cyp11b1 and Cyp11b2 mRNA 406 
levels in Nnt-/- mice with incomplete recovery in NntBAC suggested a possible mechanism for 407 
steroid depletion. In agreement with this we observed a 65% reduction in CYP11A1 at 408 
protein level in Nnt-/-  and partial restoration (to approx. 50% of Nnt+/+ levels) in NntBAC [Figure 409 
7A, 7C]. We were unable to assess CYP11B1/B2 levels since no specific murine antibody 410 
exists. The failure to completely recover CYP11A1 levels in the NntBAC mice may be due to 411 
redox imbalance in these overexpressing mice and, significantly, protein abundance mirrors 412 
the levels of corticosterone in the three mouse substrains [Figures 3A, 7A]. This is 413 
analogous to partial loss-of-function mutations in CYP11A1, which give rise to adrenal 414 
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insufficiency in humans; the proteins may retain 30-40% of wild-type activity this is 415 
insufficient to maintain normal cortisol production [Parajes et al., 2011]. 416 
In contrast the intermediate steps of steroidogenesis occur in the ER, once pregnenolone is 417 
synthesized it undergoes reactions catalysed by 3β-hydroxysteroid dehydrogenase (Hsd3b2) 418 
and 21-hydroxylase (Cyp21a1) to produce progesterone and deoxycorticosterone 419 
respectively [Figure 7B]. No significant changes were observed at mRNA or protein level in 420 
these enzymes between Nnt-/- vs Nnt+/+ mice, suggesting that mitochondrial ROS does not 421 
affect them and that a reduction of these enzymes is not the reason for their corticosterone 422 
deficiency [Figure 7A, 7C].  423 
 424 
Transcriptomics- differentially expressed genes 425 
In total 400 genes were differentially expressed in pairwise analyses between the mouse 426 
substrains [Supplementary Table 2]. Differentially expressed genes between Nnt+/+ vs Nnt-/- 427 
numbered 187 (89 up and 98 down-regulated), between Nnt-/- vs NntBAC numbered 157 (130 428 
up- and 37 down-regulated) and between Nnt+/+ vs NntBAC numbered 141 (119 up- and 22 429 
down-regulated) [Supplementary Tables 3 - 8].  430 
We hypothesized that genes with altered expression in Nnt-/- that reverted to wild-type levels 431 
in the NntBAC would be genes that were modulated by Nnt levels. 40 genes including Nnt 432 
were altered in Nnt-/- with their expression levels rescued in NntBAC. 23 of these were 433 
downregulated in Nnt-/- and back up in NntBAC, whilst 17 were upregulated in Nnt-/- and back 434 
down in NntBAC [Table 1]. Two groups of genes were enriched in this list; chaperones and 435 
haemoglobins. Specifically, there was a 25-fold increase in Hspa1a and Hspa1b in Nnt-/- 436 
mice, and these levels were restored to Nnt+/+ levels in the NntBAC mice. A smaller, but still 437 
significant, increase was observed in another heat shock (Hspb1) and a co-chaperone 438 
(Dnajb1) in Nnt-/- mice. [Figure 8A].  439 
The upregulation of heat shock proteins suggests that proteins are undergoing damage due 440 
to increased ROS and the molecular chaperone machinery is activated to correct or degrade 441 
such damaged or misfolded proteins. Interestingly alpha- and beta-haemoglobins (Hba-a1, 442 
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Hba-a2, Hbb-b1 and Hbb-b2 [aka Hbb-bs and Hbb-bt]) were 4-5-fold upregulated in Nnt-/- 443 
mice (p<0.025) and their levels returned to normal in NntBAC [Figure 8B]. Erythroid 444 
contamination of the tissues from Nnt-/- mice was considered but ruled out as other genes 445 
highly expressed in the development of erythroid lineages were not significantly upregulated 446 
(51 genes from An et al. 2014).  Recently the expression of haemoglobins in tissues other 447 
than erythrocytes has been reported suggesting their role in other basic cellular functions 448 
apart from O2 transport [Fordel et al., 2006; Vinogradov & Moens  2008]. 449 
 450 
DISCUSSION 451 
We have previously shown that mutations in NNT cause adrenal dysfunction in humans 452 
primarily affecting the zona fasciculata cells of the adrenal cortex responsible for cortisol 453 
production, and observed a 50% reduction in corticosterone levels in 3-month-old Nnt null 454 
mice [Meimaridou et al., 2012]. Further we showed mitochondrial perturbations and limited 455 
antioxidant capacity in human adrenocortical carcinoma cells where NNT expression was 456 
stably knocked-down [Meimaridou et al., 2012]. In this study, we investigated the mechanism 457 
by which NNT affects steroidogenesis in older mice by utilising three models with differing 458 
expression levels of Nnt; wild-type Nnt+/+, null Nnt-/- and two-fold overexpressing NntBAC mice. 459 
Gene expression and western blotting analysis revealed restricted levels of key 460 
mitochondrial antioxidant and steroidogenic proteins in Nnt-/- mice leading to glucocorticoid 461 
deficiency which was partially rescued in the over-expressing mice. Interestingly we 462 
demonstrate for the first time that overexpression of Nnt also negatively impacts 463 
steroidogenesis, this may be due to a persistent redox imbalance initiated by the oversupply 464 
of NADPH by NNT.  465 
 466 
The mouse inbred C57BL/6 strain is widely used for genetic and functional studies. There 467 
are two substrains of these mice depending on their site of origin; C57BL/6J established in 468 
Jackson laboratory and C57BL/6N line from the National Institutes of Health (NIH). In 2005 a 469 
spontaneous loss-of-function Nnt mutation in C57BL/6J was characterised which was 470 
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associated with impaired glucose tolerance [Ronchi et al., 2016]. Since then, these mice 471 
have been used to clarify the roles of NNT in mammalian biology.  472 
More recently, comparative genomics between C57BL/6J and C57BL/6N strains has 473 
identified many SNPs and structural variants that may contribute to the phenotypic 474 
differences between the two strains [24]. We compared expression levels of the genes noted 475 
in this publication but revealed no differences in mRNA levels exception for Nnt. This 476 
suggests that the transcriptome changes and the endocrine phenotype observed in Nnt-/- 477 
mice is largely due to differential NNT levels. 478 
 479 
In this study, we have employed, in addition, a mouse strain with transgenic rescue of Nnt 480 
expression (NntBAC) [Freeman et al., 2006]. The Nnt replacement has previously been shown 481 
to induce improvements in glucose tolerance and insulin secretion rescuing the phenotype 482 
seen in Nnt-/- mice. Corticosterone levels recovered somewhat in the NntBAC; however, they 483 
remained significantly lower than wild-type levels.  484 
 485 
In this in vivo model, we also showed that the antioxidant capacity of the Nnt-/- adrenals is 486 
significantly compromised when compared to Nnt+/+ counterparts.  The protein levels of key 487 
mitochondrial antioxidant enzymes PRDX3 and TXNRD2 are significantly reduced in Nnt-/- 488 
mice and fail to recover in NntBAC. This strongly suggests that a set level of Nnt expression is 489 
required to maintain mitochondrial redox homeostasis.  Furthermore, since mitochondrial 490 
NADPH can be regenerated not only by Nnt, but also by isocitrate dehydrogenase 2 (Idh2) 491 
and malic enzyme 3 (Me3) we excluded a possible compensatory mechanism, as 492 
expression levels of these enzymes remain unchanged between Nnt+/+ and Nnt-/- mice. 493 
Studies by other groups have similarly demonstrated that liver, heart, brain, and skeletal 494 
muscle mitochondria from Nnt-/- mice have unaltered Idh2 and Me3 enzymatic activities 495 
meaning they cannot compensate for the loss of NNT to restore NADPH levels [Nickel et al., 496 
2015, Ronchi et al., 2016]. When NNT is ablated in human adrenocortical cells we also see 497 
a disturbance of redox balance but here this does not affect cortisol output, perhaps due to 498 
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adaptive alterations in sulfiredoxin and peroxiredoxin III levels which are known to occur in 499 
H295R cells, and even primary adrenocortical cells, when grown in culture (Kil et al. 2013). 500 
NNT dysregulation not only affects the antioxidant capacity of the adrenal but also its 501 
steroidogenic capacity. We demonstrated that, in Nnt-/- mice, adrenal steroidogenesis is 502 
severely affected (86% reduction in corticosterone in 18m old mice), due to the low protein 503 
levels of a crucial steroidogenic enzyme, CYP11A1. Interestingly, NntBAC mice also exhibit 504 
glucocorticoid deficiency as indicated by 60% reduction in levels of corticosterone 505 
suggesting that Nnt overexpression also impacts on the steroidogenic output of these mice. 506 
It is increasingly recognised that redox balance is key to physiological health. Where one 507 
might assume that underexpression of antioxidants would lead to oxidative stress and 508 
overexpression would give reductive stress this is not necessarily what occurs in vivo 509 
(reviewed in [Lei et al., 2016]), with clear examples of antioxidant gene knockdown inducing 510 
reductive stress [Yan et al., 2017] and antioxidant gene overexpression also causing 511 
reductive stress [Zhang et al., 2010]. In addition, paradoxically, both reductive and oxidative 512 
insult can lead to overproduction of ROS [Barrett et al., 2004; Arrigo et al., 2005; Filomeni et 513 
al., 2005; Ali et al., 2014; Yu et al., 2014; Korge et al., 2015] which can cause protein 514 
damage. We suggest that this may be the explanation for the failure to rescue glucocorticoid 515 
secretion in the overexpressing mice with the demonstration of higher levels of lipid 516 
peroxidation in the NntBAC mice compared to Nnt+/+ mice lending support to this. 517 
 518 
Differential gene expression studies between Nnt+/+ and Nnt-/- revealed a significant 519 
upregulation of heat shock proteins in Nnt-/- mice. The failure of ROS detoxification may lead 520 
to oxidative damage of proteins and the canonical chaperone machinery will be upregulated 521 
to cope with the resultant protein misfolding and degradation. The increased ROS will also 522 
render cells more susceptible to apoptosis but heat shock proteins 27 and 70 (Hsp27 and 523 
Hsp70 respectively) are activated by mitochondrial ROS and are protective of cells 524 
preventing apoptosis by replenishing reduced glutathione and reducing intracellular iron 525 
levels [Barrett et al., 2004; Arrigo et al., 2005; Filomeni et al., 2005].  526 
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In addition to heat shock protein machinery, we show haemoglobins are regulated by NNT 527 
levels. There is a significant increase in the mRNA levels of haemoglobins in Nnt-/- mice 528 
possibly as a compensatory mechanism to combat oxidative stress. Haemoglobins are 529 
composed of alpha and beta HbA chains and their accepted main function is to transport O2 530 
to cells thorough the vascular network. However, their involvement in other fundamental 531 
cellular functions and in non-erythroid cells is increasingly being recognised. Detection of 532 
haemoglobin chains in macrophages, alveolar cells, kidney, brain and vaginal epithelial cells 533 
has been reported and their function has been linked with antioxidant defence and the 534 
regulation of mitochondrial activity [Liu et al., 1999; Arrigo et al., 2005; Newton et al., 2006; 535 
Nishi et al., 2008, Saha et al. 2017]. In adrenal, overexpression of α-Hb in rat 536 
phaeochromocytoma (PC12) cells resulted in downregulation of Gpx1 and Sod1 mRNAs 537 
suggesting that it may have a role in the scavenging of ROS [Biagioli et al., 2009; Maria et 538 
al., 2012]. Whether a similar mechanism explains the upregulation we see in intact adrenals 539 
requires further investigation. 540 
In this study, we showed that the reduced steroidogenic capacity of the adrenals in Nnt-/- and 541 
NntBAC mice is due to the inability of other antioxidant enzymes to compensate for redox 542 
imbalance resulting from altered Nnt levels. This leads to limited availability of mitochondrial 543 
CYP11A1 and a reduction in corticosterone output. Recently a similar mechanism was 544 
demonstrated to underlie the adrenal dysfunction seen in Triple A, a disorder of adrenal 545 
insufficiency, alacrima and achalasia due to mutations in AAAS encoding the protein 546 
ALADIN. A deficiency of ALADIN results in cytosolic, as opposed to mitochondrial, oxidative 547 
stress and a deficit of microsomal, rather than mitochondrial, CYP450 enzymes thereby 548 
retarding adrenal steroidogenesis [Juhlen et al., 2015].  549 
 550 
 551 
 552 
 553 
Page 20 of 41
CONCLUSIONS 554 
Using transcriptomic profiling in adrenals from three mouse substrains we showed that 555 
disturbances in adrenal redox homeostasis are mediated not only by under expression of 556 
NNT but also by its overexpression. Further we demonstrated that both under- or 557 
overexpression of NNT reduces corticosterone output implying a central role for it in the 558 
control of steroidogenesis. Reduced expression of CYP11A1, a key mitochondrial 559 
steroidogenic enzyme, mirrored the reduction in corticosterone output. Our data also 560 
suggests that oxidative stress and/or ROS damage to proteins is activating mito- and 561 
cytoprotective proteins (haemoglobins and heat shock proteins respectively) that may help 562 
maintain cell viability but do not rescue the steroidogenic phenotype. 563 
 564 
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FIGURE LEGENDS 
Figure 1. Hypothalamic-Pituitary-Adrenal (HPA) Axis and Enzymes responsible for 
cortisol production. (A) The HPA axis is a major component for adaptation of the stress 
response and cortisol release and consists of a complex set of feedback interactions that 
connect the central nervous and endocrine systems. In response to stress the 
paraventricular nucleus of the hypothalamus releases corticotropin–releasing hormone 
(CRH) and arginine vasopressin (AVP) that acts on the adrenal to stimulate glucocorticoid 
synthesis. (B) The conversion of cholesterol to cortisol is achieved by a series of catalytic 
reactions catalysed by mitochondrial (in blue) and microsomal (in pink) enzymes. Mutations 
in these key steroidogenic enzymes result in diseases of adrenal and gonadal insufficiency, 
indicated to the right with their reference numbers from online inheritance in man (OMIM). 
STAR, steroidogenic acute regulatory protein; CYP11A1, cytochrome P450 side chain 
cleavage enzyme; CYP17A1, 17-alpha hydroxylase; HSD3B2, 3-beta hydroxysteroid 
dehydrogenase, CYP21A2, 21-hydroxylase; LCAH, lipoid congenital adrenal hyperplasia; 
FGD, familial glucocorticoid deficiency; CAH, congenital adrenal hyperplasia. 
 
Figure 2. Detoxification of free radicals in the mitochondria.  
NNT encodes a protein, integral to the inner mitochondrial membrane, which under normal 
physiological conditions uses energy from the mitochondrial proton gradient to generate high 
concentrations of NADPH. This is required for many processes in the cell including the 
supply of reductive power to a network of antioxidant enzymes, specifically the glutathione 
(GSH/GSSG) and thioredoxin (Trx(SH)2/TrxS2) systems, to allow the detoxification of H2O2. 
Manganese superoxide dismutase (MnSOD) converts O2
- into H2O2 and protects ROS-
sensitive proteins from oxidative damage. H2O2 is then removed by glutathione peroxidases 
(e.g. GPX1) or peroxiredoxins (e.g. PRDX3) using GSH and Trx(SH)2 as co-factors. GSH 
and Trx(SH)2 can be regenerated by glutathione reductase (GR) and thioredoxin reductase-
2 (TXNRD2), respectively, using the reducing power from NADPH. Without NNT, the 
production of NADPH is compromised, causing the mitochondria to become more sensitive 
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to oxidative stress. Enzymes underlined in red are affected by one or more mutations in FGD 
patients.  
   
Figure 3. Biochemical and phenotypic characterisation of Nnt+/+, Nnt-/- and NntBAC mice. 
(A) Serum corticosterone in Nnt+/+, Nnt-/- and NntBAC mice was measured by LC-MS/MS and 
showed 80% and 50% reduction in Nnt-/- and NntBAC mice, respectively. (B) The 11-
deoxycorticosterone (DOC)/corticosterone ratio (CYP11B1 inhibition) was significantly higher 
in Nnt-/- and NntBAC than Nnt+/+ mice. (C) Corticosterone synthesis deteriorates in 18 months 
Nnt-/-  mice whereas there is no significant difference in the levels between 3 and 18 month 
Nnt+/+ mice. (D) H&E staining of mouse adrenals showed no major histological differences in 
architecture or zonation (left panel) and (E) Oil Red O staining revealed no difference in lipid 
content of the adrenals among the three mouse strains (right panels). Results are means ± 
standard deviation (SD); n=5 mice per group, *p<0.05, **p<0.01, ***p<0.001. 
 
Figure 4. Oxidative stress on NNT ablation. (A) Lipid peroxidation represented by MDA 
levels were measured in adrenals of Nnt+/+, Nnt-/- and NntBAC mice. MDA levels were 
significantly increased in the adrenals of Nnt-/- mice with a partial rescue in NntBAC mice 
indicating lipid damage by free radicals in adrenals upon Nnt deletion (B) The cellular levels 
of NADP/NADPH in H295R cells with a stable knockdown of NNT (NNT-KD) were measured 
by using a luciferin based assay. Total cellular NADP/NADPH ratio was significantly higher 
in NNT-KD compared to scramble (SCR), suggesting that NNT is required to maintain the 
redox state of the intracellular NADPH and NADP+ pools. (C) Mitochondria respiration was 
assessed by measuring oxygen consumption rates using Seahorse XF-96 metabolic Flux 
Analyser. NNT-KD cells had a significantly lower basal OCAR compared to scrambled cells; 
the addition of oligomycin (complex V inhibitor) resulted in an OCAR decline which was 
significantly lower in NNT-KD cells compared to controls, indicating that the ATP turnover 
was compromised in NNT-KD cells. Furthermore, maximal respiration capacity as measured 
by the addition of an uncoupling agent, FCCP, was also significantly lower in NNT-KD cells. 
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The addition of rotenone and antimycin (complex I and II inhibitors respectively) reflecting 
the spare respiratory capacity of the cells resulted in a reduction of OCAR which was 
significantly lowered in NNT-KD cells when compared to scrambled cells. OCAR values 
were normalised to total protein concentration. Results are means ± standard deviation (SD); 
n=5 per group, *p<0.05, **p<0.01, ***p<0.001.  
 
Figure 5. RNA-seq analysis flowchart and differential gene expression.  
(A) Flowchart of initial RNA-seq analysis of mouse adrenals. (B) Representative heat map of 
RNA-seq analysis for substrain-specific differentially expressed genes (between Nnt-/- and 
NntBAC) within mouse adrenals. Genes were clustered by Partek hierarchical clustering 
based on gene expression values. Normalisation was performed by genes shifted to mean of 
zero and scaled to standard deviation of 1. Arbitrary signal intensity from RNA-seq data is 
represented by colours (red, higher expression, blue lower expression).  (C) Venn diagram 
showing the number of differential genes in pairwise analyses between; Nnt+/+ vs Nnt-/- (187), 
Nnt-/-  vs NntBAC (157) and Nnt+/+ vs NntBAC (141). Genes at the intersection of the pairwise 
analyses Nnt+/+ vs Nnt-/-  and Nnt-/-  vs NntBAC represent genes that are modulated by Nnt 
levels (39 + Nnt) [see Table 1 and Supplementary Tables 3-8]. 
 
Figure 6. Effect of NNT loss on redox homeostasis. 
(A) mRNA Nnt levels in the three mouse strains. (B) No NNT protein expression was 
observed in Nnt-/- (western blot) however there was a two-fold upregulation in NntBAC when 
compared to Nnt+/+. (C) protein levels of TXNRD2, PRDX3 and GPX1 in the Nnt+/+, Nnt-/- and 
NntBAC mouse adrenals were normalised to actin with representative western blots shown to 
the right.  
 
Figure 7. Effect of NNT loss on steroidogenesis. (A) mRNA and protein fold change of 
enzymes involved in glucocorticoid synthesis, starting from cholesterol transport (STAR), to 
the first step of steroid synthesis (mitochondrial CYP11A1), and subsequent reactions 
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catalysed by microsomal enzymes (HSD3B2, CYP21A1) to the final synthesis of 
corticosterone. (B) The conversion of cholesterol to corticosterone in mice is achieved by a 
series of catalytic reactions catalysed by mitochondrial (in blue) and microsomal (in pink) 
enzymes (right panel). (C) Panel of western blots representing changes in expression of 
protein involved in steroidogenesis. Results are means ± standard deviation (SD); n=5 mice 
per group, *p<0.05, **p<0.01, ***p<0.001.  
 
Figure 8. Enrichment of gene pathways in response to oxidative stress.  
(A) mRNA levels of heat shock proteins revealed significant upregulation (Hspa1a 26-fold; 
Hspa1a 25-fold; Hsph1 3-fold; Dnajb1 6-fold) in Nnt-/-  mice and restoration of the levels in 
NntBAC mouse adrenals. (B) Similarly haemoglobin gene mRNA expression was significantly 
upregulated in Nnt-/- mice when compared to Nnt+/+ and reversed in NntBAC (Hbb-b1 4-fold; 
Hbb-b2 5-fold; Hba-a1 5-fold; Hba-a2 5-fold).  
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Figure 2 
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Figure 4 
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RNAseq on mouse adrenals n=5 per group 
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Genes downregulated in Nnt
-/-
 and restored in Nnt
BAC
 
Gene ID Gene Description 
    
1500015O10Rik RIKEN cDNA 1500015O10 gene 
9330151L19Rik ENSMUSG00000097061 - Uncharacterized protein 
A530020G20Rik RIKEN cDNA A530020G20 gene 
C1qtnf6 C1q and tumor necrosis factor related protein 6 
Ccdc160 Coiled-coil domain containing 160 
Ctxn3 Cortexin 3 
Cyp21a2-ps Cyp21a2 pseudogene 
E330017L17Rik RIKEN cDNA E330017L17 gene 
Epb4.1l4aos Erythrocyte membrane protein band 4.1 like 4a, opposite strand 
Gnat2 Guanine nucleotide binding protein, alpha transducing 2 
Ism1 Isthmin 1 homolog (zebrafish) 
Kcnn2 
Potassium intermediate/small conductance calcium-activated channel, 
subfamily N, member 2 
Lilr4b Leukocyte immunoglobulin-like receptor, subfamily B, member 4B 
Ly96 Lymphocyte antigen 96 
Nnt Nicotinamide nucleotide transhydrogenase 
Pacsin3 Protein kinase C and casein kinase substrate in neurons 3 
Sox12 SRY-box containing gene 12 
Steap1 Six transmembrane epithelial antigen of the prostate 1 
Trim12c Tripartite motif-containing 12C 
Trim21 Tripartite motif-containing 21 
Trim30d Tripartite motif-containing 30D 
Tuft1 Tuftelin 1 
Vsnl1 Visinin-like 1 
    
Genes upregulated in Nnt
-/-
 and restored in Nnt
BAC
 
Gene ID Gene Description 
    
Arl4d ADP-ribosylation factor-like 4D 
Cwc25 CWC25 spliceosome-associated protein homolog (S. cerevisiae) 
Cyr61 Cysteine rich protein 61 
Dnajb1 DnaJ (Hsp40) homolog, subfamily B, member 1 
Egr1 Early growth response 1 
Fam46a Family with sequence similarity 46, member A 
Gadd45g Growth arrest and DNA-damage-inducible 45 gamma 
Hba-a1 Hemoglobin alpha, adult chain 1 
Hba-a2 Hemoglobin alpha, adult chain 2 
Hbb-bs Hemoglobin, beta adult s chain 
Hbb-bt Hemoglobin, beta adult t chain 
Ier2 Immediate early response 2 
Ier3 Immediate early response 3 
Irs2 Insulin receptor substrate 2 
Klf4 Kruppel-like factor 4 (gut) 
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Nr4a2 Nuclear receptor subfamily 4, group A, member 2 
Zfp36l2 Zinc finger protein 36, C3H type-like 2 
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